RVL 021
Alternative Names: RVL-021Latest Information Update: 03 Jan 2024
Price :
$50 *
At a glance
- Originator Unravel Biosciences
- Class Sleep disorder therapies; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Neurodevelopmental disorders; Sleep disorders
Most Recent Events
- 19 Dec 2023 Early research in Mental disorders diagnosed in childhood in USA (unspecified route) prior to December 2023 (Unravel Biosciences pipeline; December 2023)
- 19 Dec 2023 Early research in Sleep disorders in USA (unspecified route) prior to December 2023 (Unravel Biosciences pipeline; December 2023)